Inpatients aged 65 to 79 years who were scheduled for ERCP were recruited into the study.
Conditions
Interventions
In group M, 40 mg/kg magnesium sulfate diluted with normal saline to a total volume of 100 ml was administered for 15 minutes prior to the beginning of the procedure. An initial bolus dose of 1 mg/kg
Sponsors
Department of Anaesthesiology, People's Hospital of Chongqing Banan District
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: After obtaining written informed consent, adult patients of American Society of Anesthesiologists (ASA) physical status I through III aged between 65 and 79 years of either sex scheduled for ERCP under sedation were included in this study.
Exclusion criteria
Exclusion criteria: 1, a history of adverse events with prior sedation; 2, known hypersensitivity to any of the drugs that would be used in the study; 3, patients with ASA Class 4 or 5; 4, pre-existing hypoxemia (SpO2 < 90%); 5, hypotension (systolic blood pressure < 90mmHg) or uncontrolled hypertension (systolic blood pressure > 170mmHg, diastolic blood pressure > 100mmHg); 6, severe cardiac, renal, neurological, or liver diseases; 7, patients who had taken any sedative drug within the previous 24 hours and those who refused participation;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes was propofol requirements. | — |
Countries
Asia(except Japan)
Contacts
Public Contactjie Chen
People's Hospital of Chongqing Banan District Department of Anaesthesiology
Outcome results
None listed